×

Notice

The forum is in read only mode.
Welcome, Guest
Username: Password: Remember me

Profile for Janet UK

Janet UK's Avatar
  • Rank : New Member
  • New Member
  • Register Date: 23 Mar 2017
  • Last login: 6 years 6 months ago
  • Time Zone: UTC +11:00
  • Local Time: 18:14
  • Posts : 12
  • Thank you received: 21
  • Profile Views : 1095
  • Location : England

Signature

Infected 1981 by contaminated blood products
Geno 3
Interferon/Ribavirin 2009 relapsed after EOT
Generic Sof/Dac started 28 Jan 2017
Baseline VL 24.7 million
UNDETECTED after 26 days.


12 messages
  • Page:
  • 1
  • 2

Janet UK's recent posts

Message / Subject Replies / Views Last Post
file
Janet UK, 6 years 7 months ago
Category: Genotype 3 (37%)
Replies:10
Views:2982
Last Post by coral
6 years 7 months ago
file
Janet UK, 6 years 7 months ago
Category: Genotype 3 (37%)
Replies:10
Views:2982
Last Post by coral
6 years 7 months ago
file
Janet UK, 6 years 10 months ago
Category: Genotype 3 (37%)
Replies:5
Views:2772
Last Post by Gaj
6 years 10 months ago
file
Janet UK, 6 years 10 months ago
Category: Genotype 3 (37%)
Replies:5
Views:2772
Last Post by Gaj
6 years 10 months ago
file
Janet UK, 6 years 11 months ago
Category: Genotype 3 (37%)
Replies:12
Views:3293
Last Post by Janet UK
6 years 11 months ago
file
Janet UK, 6 years 11 months ago
Category: Genotype 3 (37%)
Replies:12
Views:3293
Last Post by Janet UK
6 years 11 months ago
file
Janet UK, 6 years 11 months ago
Category: Genotype 3 (37%)
Replies:12
Views:3293
Last Post by Janet UK
6 years 11 months ago
file
Janet UK, 6 years 11 months ago
Category: Genotype 3 (37%)
Replies:12
Views:3293
Last Post by Janet UK
6 years 11 months ago
file
Janet UK, 6 years 11 months ago
Category: Genotype 3 (37%)
Replies:12
Views:3293
Last Post by Janet UK
6 years 11 months ago
file
Janet UK, 6 years 11 months ago
Category: Genotype 3 (37%)
Replies:12
Views:3293
Last Post by Janet UK
6 years 11 months ago
  • Page:
  • 1
  • 2
Time to create page: 0.073 seconds

Copyright © 2015-2020 FixHepC

Back to Top